- Home
- CABO vs XERS Comparison
CABO vs XERS Comparison
Compare CABO & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CABO
- XERS
- Stock Information
- Founded
- CABO 1980
- XERS 2005
- Country
- CABO United States
- XERS United States
- Employees
- CABO N/A
- XERS N/A
- Industry
- CABO Cable & Other Pay Television Services
- XERS Biotechnology: Pharmaceutical Preparations
- Sector
- CABO Telecommunications
- XERS Health Care
- Exchange
- CABO Nasdaq
- XERS Nasdaq
- Market Cap
- CABO 764.7M
- XERS 628.7M
- IPO Year
- CABO N/A
- XERS 2018
- Fundamental
- Price
- CABO $128.00
- XERS $4.51
- Analyst Decision
- CABO Hold
- XERS Strong Buy
- Analyst Count
- CABO 3
- XERS 6
- Target Price
- CABO $231.00
- XERS $6.25
- AVG Volume (30 Days)
- CABO 240.0K
- XERS 2.1M
- Earning Date
- CABO 07-31-2025
- XERS 08-07-2025
- Dividend Yield
- CABO 6.99%
- XERS N/A
- EPS Growth
- CABO N/A
- XERS N/A
- EPS
- CABO N/A
- XERS N/A
- Revenue
- CABO $1,555,831,000.00
- XERS $222,551,000.00
- Revenue This Year
- CABO N/A
- XERS $35.03
- Revenue Next Year
- CABO N/A
- XERS $18.31
- P/E Ratio
- CABO N/A
- XERS N/A
- Revenue Growth
- CABO N/A
- XERS 29.88
- 52 Week Low
- CABO $125.35
- XERS $2.03
- 52 Week High
- CABO $437.00
- XERS $6.07
- Technical
- Relative Strength Index (RSI)
- CABO 33.40
- XERS 46.97
- Support Level
- CABO $134.66
- XERS $4.30
- Resistance Level
- CABO $138.44
- XERS $4.79
- Average True Range (ATR)
- CABO 7.25
- XERS 0.23
- MACD
- CABO 1.81
- XERS -0.01
- Stochastic Oscillator
- CABO 11.62
- XERS 25.93
About CABO Cable One Inc.
Cable One Inc. is a telecommunications company that generates revenue from providing broadband, voice, and video services to both residential and business customers. From a product standpoint, the majority of revenue comes from data and video services, which are subscription-based and billed monthly. The company also offers Sparklight TV, an Internet Protocol Television (IPTV) service that enables customers using the Sparklight TV app to stream video channels from the cloud. Additionally, the company earns advertising revenue by selling airtime on its video channels, and it provides voice services over Internet protocols. Cable One Inc. owns its telecommunications infrastructure.
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).